ATH 33.3% 0.4¢ alterity therapeutics limited

re: dosing commenced in phase 2a of bt2 trial of a Tudit,...

  1. 11,522 Posts.
    re: dosing commenced in phase 2a of bt2 trial of a Tudit, judging from today’s announcement, I’m leaning towards the positive.

    The quinolines are exceptional chelating agents. Yet to comb through and learn the chem and processes thoroughly, but does look very good at this point.

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.